Raffles Medical Group Ltd (SG:BSL)
SGX:BSL
Want to see SG:BSL full AI Analyst Report?
BSL Stock Chart & Stats
S$1.02
>-S$0.01(-0.60%)
At close: 4:00 PM EST
S$1.02
>-S$0.01(-0.60%)
Day’s Range― - ―
52-Week RangeS$0.93 - S$1.09
Previous CloseN/A
Volume814.20K
Average Volume (3M)1.13M
Market Cap
S$1.78B
Enterprise ValueS$1.55B
Total Cash (Recent Filing)S$334.18M
Total Debt (Recent Filing)S$83.83M
Price to Earnings (P/E)36.6
Beta0.41
Next Earnings
Aug 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.45%
Share Statistics
EPS (TTM)0.04
Shares Outstanding1,884,544,900
10 Day Avg. Volume1,100,720
30 Day Avg. Volume1,133,593
Financial Highlights & Ratios
PEG Ratio1.95
Price to Book (P/B)1.78
Price to Sales (P/S)2.47
P/FCF Ratio19.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.04
Revenue Forecast (FY)S$801.23M
Bulls Say, Bears Say
Bulls Say
Capital Return ProgramRevised capital return plans that include higher dividend payouts and a planned share buyback program should provide direct support to the share price and investor sentiment.
China Hospital TurnaroundLosses at China hospitals are projected to narrow as partnerships with teaching hospitals boost referrals and converting health screenings into treatments raises utilization and fixed cost absorption.
Revenue Mix ImprovementHospital revenue growth is supported by higher patient volumes, larger average bills, and improved operational efficiency, which can lift top line and margins.
Bears Say
Insurance Margin SensitivityInsurance profitability is sensitive to medical cost trends and an unfavorable claims ratio could materially harm underwriting results and overall margins.
Insurer Pricing PressurePrice pressure from insurers and competition from new government hospitals constrains the ability to raise patient bills and limits revenue per case.
Singapore Demand WeaknessSluggish patient volumes in Singapore curb revenue growth and reduce the potential to achieve greater fixed cost absorption in the domestic business.
Raffles Medical Group News
BSL FAQ
What was Raffles Medical Group Ltd’s price range in the past 12 months?
Raffles Medical Group Ltd lowest share price was S$0.93 and its highest was S$1.09 in the past 12 months.
What is Raffles Medical Group Ltd’s market cap?
Raffles Medical Group Ltd’s market cap is S$1.78B.
When is Raffles Medical Group Ltd’s upcoming earnings report date?
Raffles Medical Group Ltd’s upcoming earnings report date is Aug 03, 2026 which is in 55 days.
How were Raffles Medical Group Ltd’s earnings last quarter?
Raffles Medical Group Ltd released its earnings results on Feb 22, 2026. The company reported S$0.021 earnings per share for the quarter, beating the consensus estimate of N/A by S$0.021.
Is Raffles Medical Group Ltd overvalued?
According to Wall Street analysts Raffles Medical Group Ltd’s price is currently Overvalued.
Does Raffles Medical Group Ltd pay dividends?
Raffles Medical Group Ltd pays a Annually dividend of S$0.03 which represents an annual dividend yield of 2.45%. See more information on Raffles Medical Group Ltd dividends here
What is Raffles Medical Group Ltd’s EPS estimate?
Raffles Medical Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Raffles Medical Group Ltd have?
Raffles Medical Group Ltd has 1,884,544,900 shares outstanding.
What happened to Raffles Medical Group Ltd’s price movement after its last earnings report?
Raffles Medical Group Ltd reported an EPS of S$0.021 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Raffles Medical Group Ltd?
Currently, no hedge funds are holding shares in SG:BSL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Raffles Medical Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
15.09%
12-Months-Change
Fundamentals
Return on Equity
4.62%
Trailing 12-Months
Asset Growth
-0.91%
Trailing 12-Months
Company Description
Raffles Medical Group Ltd
Raffles Medical Group Ltd (RMG), a prominent Singapore-headquartered company, delivers integrated private healthcare services across Singapore, Greater China, Vietnam, Cambodia, and Japan. Its operations are structured into Healthcare Services, Hospital Services, and Investment Holdings segments. The group's flagship institution, Raffles Hospital, functions as a tertiary care facility, offering a broad spectrum of medical services. These include oncology, pediatrics and women's health, traditional Chinese medicine, counseling, dental care, dialysis, diabetes and endocrinology, ENT, ophthalmology, fertility treatments, cardiology, internal medicine, neuroscience, pain management, rehabilitation, orthopedics, dermatological and aesthetic services, general surgery, nuclear medicine, and urology. Beyond the hospital, RMG provides emergency services, family medicine, comprehensive health screening, and a variety of multi-disciplinary specialist clinic services. Additionally, the company engages in the trade of pharmaceutical and nutraceutical products, and diagnostic equipment. It also offers advisory and consultancy services, develops IT solutions, and undertakes research and experimental development in biotechnology, life sciences, and medical science. The company was founded in 1976.
Technical Analysis
Thomson Medical Group Ltd.
―
Aoxin Q&M Dental Group Ltd.
―
ISEC Healthcare Ltd
―
OUE Lippo Healthcare Limited
―
Bangkok Dusit Medical Services Public Co Ltd Shs UnSp Singapore Depositary Receipt Repr 2/1 Sh
―
Options Prices
Currently, No data available
---